By selecting the Yes option, leaving Amgen.com.sg option you understand that you are leaving the corporate page of Amgen Singapore and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Singapore is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Singapore. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
New take-home discovery kits bring real-world science into homes, widening access to STEM learning for underserved youths and supporting early interest in science pathways
Singapore (6 June 2026) – Amgen Singapore (NASDAQ:AMGN) and Science Centre Singapore today launched SPARKLABS by AMPower, a take-home, hands-on biotechnology discovery programme that puts real-world science into the hands of youths aged 10 to 14 through guided experiments, automation concepts, and basic coding missions.
A pilot of 1,000 SPARKLABS kits will be distributed through the AMPower Science Camp, part of Amgen Singapore’s flagship community outreach programme, in partnership with Science Centre Singapore, expanding access to hands-on STEM learning for youths across Singapore, particularly those from underserved communities.
Through mission-based learning, participants step into the role of “Lab Heroes,” completing hands-on challenges that reflect how biotechnology works in the real world—making science tangible, practical, and relevant beyond the classroom.
“At Amgen, we believe every scientist starts with curiosity, but curiosity needs opportunity. Through SPARKLABS by AMPower, we’re putting real-world biotechnology directly into the hands of youths, so they can experiment and see how science is used to develop medicines. As a science-led company, this is how we make science tangible early, by building confidence, opening doors, and expanding access to opportunity,” said Wallace Torres, Vice President, Amgen Singapore Site Operations.
“SPARKLABS by AMPower reflects our commitment at Science Centre Singapore to make science accessible, engaging, and relevant for everyone. Its hands-on format allows students to experience first-hand how science connects to real-world challenges and careers. Partnerships like this allow us to broaden access to meaningful STEM experiences and empower the next generation to build confidence, curiosity, and a deeper understanding of science in their everyday lives,” added Dr Lee Song Choon, Senior Director, Education, Dome & Observatory Division, Science Centre Board.
As a global biotechnology company that discovers, develops, manufactures, and delivers innovative medicines, Amgen supports STEM outreach to broaden access to hands-on science learning and spark early curiosity, especially for youths who may have fewer opportunities to explore science beyond the classroom.
The launch of SPARKLABS builds on the longstanding partnership between Amgen Singapore and Science Centre Singapore, which has supported science education initiatives since 2016, including the Amgen Biotech Experience (ABE) and AMPower Science Camps.
An international programme funded by the Amgen Foundation, ABE Singapore continues to advance biotech education for secondary and tertiary students—sparking curiosity through hands-on learning while supporting teachers with professional training, access to research-grade equipment, and updated curriculum. Since its inception, the programme has reached more than 5,200 students across 98 schools, helping bridge classroom learning with real-world scientific application.
AMPower, launched in 2020, brings science beyond textbooks and into the hands of youths and their families, particularly those with fewer opportunities to access hands-on STEM learning. Through practical, age-appropriate experiences that build curiosity, confidence, and a sense of possibility, the programme has reached more than 600 participants across 11 runs, engaging youths from diverse backgrounds through community partnerships. Nearly half of participants have been girls, reinforcing a shared commitment to widening access and making STEM pathways more inclusive.
SPARKLABS by AMPower extends this approach beyond the camp setting through structured, take-home biotechnology discovery kits. Through hands-on missions in applied science, automation, and basic coding, it enables more sustained engagement with real-world science—giving more youths the opportunity to explore, experiment, and see how science comes to life.
About Science Centre Singapore
Science Centre Singapore, a non-formal educational institution and leading regional Science Centre, along with its group of attractions, brings out the wonders of Science, Technology, Engineering and Mathematics (STEM) through its unique blend of exhibitions, educational programmes, and events. A role model of creativity and innovation, Science Centre Singapore has captured the evolution of scientific developments for nearly five decades. The Centre and its partners have played a pivotal role in transforming the way students and the public interact with and learn about STEM. Since 1977, the Centre has welcomed over 30 million visitors and inspired them with more than 1,000 exhibits spread across 14 exhibition galleries and outdoor exhibition spaces.
The Centre’s group of attractions include Omni-Theatre and KidsSTOP™. The Omni-Theatre is an immersive dual-technology edutainment destination fitted with Southeast Asia’s largest seamless dome screen featuring the latest and brightest 8k digital full-dome system in the world. KidsSTOP™ – Where every child gets to Imagine, Experience, Discover and Dream – is Singapore’s first children’s science centre offering an enriching experience through purposeful play for children aged 18 months to 8 years old. For more information, please visit www.science.edu.sg.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.
###
MEDIA CONTACTS:
Amgen Singapore | Sandpiper, ASM@sandpipercomms.com
Science Centre Singapore | AKA Asia, sciencecentrepr@aka-asia.com